| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.
|
Schizophr Res
|
2006
|
1.88
|
|
2
|
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
|
J Clin Psychiatry
|
2009
|
1.61
|
|
3
|
Antimuscarinic persistence patterns in newly treated patients with overactive bladder: a retrospective comparative analysis.
|
Int Urogynecol J
|
2013
|
1.57
|
|
4
|
Cognitive function impairment in patients with neuropathic pain under standard conditions of care.
|
J Pain Symptom Manage
|
2007
|
1.50
|
|
5
|
A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.
|
BMC Neurol
|
2011
|
1.21
|
|
6
|
Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q).
|
Value Health
|
2008
|
1.18
|
|
7
|
Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool.
|
Health Qual Life Outcomes
|
2010
|
1.14
|
|
8
|
Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component.
|
Health Qual Life Outcomes
|
2007
|
1.11
|
|
9
|
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort.
|
Schizophr Res
|
2010
|
1.09
|
|
10
|
Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study.
|
Arthritis Res Ther
|
2009
|
1.05
|
|
11
|
Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
|
Bipolar Disord
|
2008
|
1.03
|
|
12
|
A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study.
|
Schizophr Res
|
2008
|
1.01
|
|
13
|
Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study.
|
J Alzheimers Dis
|
2010
|
0.99
|
|
14
|
Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care.
|
J Affect Disord
|
2010
|
0.96
|
|
15
|
[Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain].
|
Med Clin (Barc)
|
2006
|
0.94
|
|
16
|
Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings.
|
Rheumatol Int
|
2009
|
0.92
|
|
17
|
Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions.
|
Eur J Pain
|
2006
|
0.92
|
|
18
|
The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice.
|
Health Qual Life Outcomes
|
2012
|
0.91
|
|
19
|
Development and validation of the Migraine Screen Questionnaire (MS-Q).
|
Headache
|
2005
|
0.89
|
|
20
|
Using the WHOQOL-BREF in persons with dementia: a validation study.
|
Alzheimer Dis Assoc Disord
|
2011
|
0.86
|
|
21
|
Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination.
|
BMC Musculoskelet Disord
|
2009
|
0.85
|
|
22
|
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study.
|
Eur Neuropsychopharmacol
|
2011
|
0.85
|
|
23
|
Prevalence and characterization of neuropathic pain in a primary-care setting in Spain: a cross-sectional, multicentre, observational study.
|
Clin Drug Investig
|
2009
|
0.85
|
|
24
|
[Adaptation and validation of the Health Utilities Index Mark 3 into Spanish and correction norms for Spanish population].
|
Med Clin (Barc)
|
2003
|
0.85
|
|
25
|
New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care.
|
BMC Neurol
|
2010
|
0.84
|
|
26
|
[Prevalence of neuropathic pain in Spain: clinical, working and health care implications].
|
Med Clin (Barc)
|
2005
|
0.84
|
|
27
|
Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
|
Schizophr Res
|
2007
|
0.84
|
|
28
|
Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain.
|
Clin Drug Investig
|
2006
|
0.83
|
|
29
|
Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?
|
Ann Gen Psychiatry
|
2011
|
0.83
|
|
30
|
Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
|
Eur Addict Res
|
2011
|
0.82
|
|
31
|
Efficacy of second-generation-antipsychotics in the treatment of negative symptoms of schizophrenia: a meta-analysis of randomized clinical trials.
|
Rev Psiquiatr Salud Ment
|
2011
|
0.82
|
|
32
|
Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain. Description and associated factors. The Psychosp study.
|
Soc Psychiatry Psychiatr Epidemiol
|
2004
|
0.81
|
|
33
|
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.
|
Eur J Health Econ
|
2009
|
0.81
|
|
34
|
Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings.
|
Pain Med
|
2010
|
0.81
|
|
35
|
The cost of generalized anxiety disorder in primary care settings: results of the ANCORA study.
|
Community Ment Health J
|
2012
|
0.81
|
|
36
|
Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model.
|
BMC Urol
|
2011
|
0.81
|
|
37
|
Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form.
|
Clin Drug Investig
|
2012
|
0.80
|
|
38
|
Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia.
|
Schizophr Res
|
2012
|
0.80
|
|
39
|
A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
|
Eur J Health Econ
|
2004
|
0.80
|
|
40
|
A confirmatory study of the Combined Index of Severity of Fibromyalgia (ICAF*): factorial structure, reliability and sensitivity to change.
|
Health Qual Life Outcomes
|
2011
|
0.80
|
|
41
|
Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S).
|
Schizophr Res
|
2009
|
0.80
|
|
42
|
Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction.
|
J Clin Pharmacol
|
2009
|
0.80
|
|
43
|
Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
|
Schizophr Res
|
2011
|
0.80
|
|
44
|
Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder.
|
Health Qual Life Outcomes
|
2009
|
0.79
|
|
45
|
Health and non-health care resources use in the management of adult outpatients with drug-resistant epilepsy in Spain: a cost-of-illness study (LINCE study).
|
Epilepsy Res
|
2008
|
0.79
|
|
46
|
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain.
|
Clinicoecon Outcomes Res
|
2012
|
0.79
|
|
47
|
Modeling the predictive value of pain intensity on costs and resources utilization in patients with peripheral neuropathic pain.
|
Clin J Pain
|
2015
|
0.79
|
|
48
|
Driving cost factors in adult outpatients with refractory epilepsy: a daily clinical practice in clinics of neurology in Spain.
|
Epilepsy Res
|
2008
|
0.79
|
|
49
|
Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice.
|
Clin Drug Investig
|
2012
|
0.79
|
|
50
|
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2004
|
0.79
|
|
51
|
Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
|
Clin Ther
|
2010
|
0.79
|
|
52
|
Cost savings associated with early initiation of pregabalin in the management of peripheral neuropathic pain.
|
Clin J Pain
|
2013
|
0.79
|
|
53
|
Costs and health resources utilization following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain: a post hoc analysis.
|
Pain Pract
|
2011
|
0.79
|
|
54
|
[Spanish cultural adaptation and psychometrical validation of the Treatment Benefit Scale (TBS) in the symptomatic treatment of overactive bladder].
|
Med Clin (Barc)
|
2012
|
0.78
|
|
55
|
Treatment satisfaction after switching to another therapy in Spanish orthopaedic clinic outpatients with knee or hip osteoarthritis previously refractory to paracetamol.
|
Clin Drug Investig
|
2012
|
0.78
|
|
56
|
[Linguistic adaptation into Spanish and validation of the Arthritis Treatment Satisfaction Questionnaire].
|
Med Clin (Barc)
|
2005
|
0.78
|
|
57
|
Structural validity of a 16-item abridged version of the Cervantes Health-Related Quality of Life scale for menopause: the Cervantes Short-Form Scale.
|
Menopause
|
2015
|
0.78
|
|
58
|
Validation of the Spanish version of the DEMQOL system.
|
Int Psychogeriatr
|
2010
|
0.77
|
|
59
|
An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings.
|
Prim Care Diabetes
|
2012
|
0.77
|
|
60
|
A cost-effectiveness analysis of the effect of pregabalin versus usual care in the treatment of refractory neuropathic pain in routine medical practice in Spain.
|
Pain Med
|
2012
|
0.77
|
|
61
|
Linguistic adaptation and validation into Spanish of the Diagnostic Interview for Borderline Personality Disorders-Revised (DIB-R).
|
Curr Med Res Opin
|
2005
|
0.77
|
|
62
|
Clinical and resource utilization patterns in patients with refractory neuropathic pain prescribed pregabalin for the first time in routine medical practice in primary care settings in Spain.
|
Pain Med
|
2013
|
0.77
|
|
63
|
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain.
|
BMC Urol
|
2013
|
0.77
|
|
64
|
Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.
|
Soc Psychiatry Psychiatr Epidemiol
|
2012
|
0.76
|
|
65
|
A cost-consequences analysis of the effect of pregabalin in the treatment of painful radiculopathy under medical practice conditions in primary care settings.
|
Pain Pract
|
2010
|
0.76
|
|
66
|
[Linguistic adaptation into Spanish and psychometric validation of the ID-Pain questionnaire for the screening of neuropathic pain].
|
Med Clin (Barc)
|
2008
|
0.76
|
|
67
|
Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an observational and retrospective study.
|
BMC Urol
|
2012
|
0.76
|
|
68
|
Cost effectiveness of fesoterodine and tolterodine for the treatment of overactive bladder with urge urinary incontinence in Spain and Finland.
|
Clin Drug Investig
|
2014
|
0.76
|
|
69
|
A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs.
|
Ann Clin Psychiatry
|
2013
|
0.75
|
|
70
|
The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients.
|
BMC Psychiatry
|
2013
|
0.75
|
|
71
|
Adding pregabalin or gabapentin for the management of community-treated patients with painful diabetic peripheral neuropathy: a comparative cost analysis.
|
Clin Drug Investig
|
2013
|
0.75
|
|
72
|
Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain.
|
Clinicoecon Outcomes Res
|
2013
|
0.75
|
|
73
|
Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness Tool.
|
Int Urogynecol J
|
2012
|
0.75
|
|
74
|
[Health-related quality of life studies in clinical trials: Assessment of their methodological quality through a check-list].
|
Med Clin (Barc)
|
2009
|
0.75
|
|
75
|
The Cornell-Brown scale for quality of life in dementia: Spanish adaptation and validation.
|
Alzheimer Dis Assoc Disord
|
2013
|
0.75
|
|
76
|
The Spanish version of the dementia quality of life questionnaire: a validation study.
|
Aging Ment Health
|
2011
|
0.75
|
|
77
|
Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trial.
|
Clin Drug Investig
|
2007
|
0.75
|
|
78
|
Cultural adaptation, validation and development of a spanish brief version of the diabetes fear of injecting and self-testing questionnaire.
|
Endocrinol Nutr
|
2008
|
0.75
|
|
79
|
A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain.
|
Actas Esp Psiquiatr
|
2013
|
0.75
|
|
80
|
Labor productivity in migraine patients: primary care contribution to occupational medicine.
|
J Occup Environ Med
|
2008
|
0.75
|